Do obesity drugs treat addiction? Huge study hints at their promise

A new study suggests that GLP-1 medications, typically used for obesity and type 2 diabetes, might help prevent addiction to substances like alcohol, cocaine, and opioids. The research, published in The BMJ, analyzed health records from over 600,000 veterans and found that these drugs could reduce the risk of developing substance-use disorders and lower the risk of dying from addiction by 50% for those already struggling. The study highlights the potential of GLP-1 drugs to treat various addictions, although larger clinical trials are needed to confirm these findings. This discovery is significant because it could lead to new treatments for addiction, a major health issue affecting many people. QUESTION: How might the potential use of GLP-1 medications for addiction change the way society views and treats substance-use disorders?